We are proud to announce that PhenoPath is now a Quest Diagnostics Company.
IHC
Methodology: IHC
Clinical Significance:
Identifies a subset of carcinomas. Co-analysis with expression of cytokeratin 20 can be helpful in the identification of the primary site of carcinomas presenting at metastatic sites.
Subcellular Localization: Cytoplasmic
Organ: Lung
Disease State: Carcinomas of Unknown Primary
CPT Code(s): 88342 or 88341 (reference only; CPTs may vary)
Turnaround Time: Within 1-2 business days of receipt
Schedule: Monday - Friday
Specimen Requirements:
• Formalin-fixed, paraffin-embedded (FFPE) tissue block or cell block - OR -
• 1 unstained slide for each test requested plus 3-4 additional unstained slides cut at 4µm